Fredric Chan

Pharmacoeconomics of entecavir treatment for chronic hepatitis B

J. You, Fredric W. H. Chan, J. You, 2008, Expert opinion on pharmacotherapy.

The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy – a decision analysis

J. You, R. Wong, G. Cheng, 2004, Thrombosis and Haemostasis.

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

J. You, R. Wong, G. Cheng, 2005, British journal of clinical pharmacology.